الصفحة الرئيسية>>Signaling Pathways>> PROTAC>>MZ1

MZ1

رقم الكتالوجGC18729

MZ1 هو PROTAC متصل بواسطة روابط لـ von Hippel-Lindau و BRD4. MZ1 يحث بشكل فعال وسريع على إزالة قابلة للعكس وطويلة الأمد وانتقائية لـ BRD4 على BRD2 و BRD3. Kds لـ 382/120 و 119/115 و 307/228 نانومتر لـ BRD4 BD1 / 2 و BRD3 BD1 / 2 و BRD2 BD1 / 2 على التوالي.

Products are for research use only. Not for human use. We do not sell to patients.

MZ1 التركيب الكيميائي

Cas No.: 1797406-69-9

الحجم السعر المخزون الكميّة
500μg
47٫00
متوفر
1mg
54٫00
متوفر
5mg
180٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com

مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products
MZ1 is a hybrid compound that drives the selective proteasomal degradation of bromodomain-containing protein 4 (BRD4). It is characterized as a proteolysis-targeting chimera (PROTAC) and contains JQ-1, which binds bromo- and extra-terminal (BET) proteins, linked to a ligand for the E3 ubiquitin ligase VHL. MZ1 induces the selective degradation of BRD4 in HeLa cells when used at 0.1-0.5 uM. At concentrations of 2-10 uM, MZ1 causes the removal of BRD2, BRD3, and BRD4. BRD protein removal is evident within four hours of adding MZ1 and persists for at least 48 hours, unless MZ1 is removed.

مراجعات

Review for MZ1

Average Rating: 5 ★★★★★ (Based on Reviews and 40 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for MZ1

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.